Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of MDT-2113 Drug-Eluting Balloon (DEB) vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery

NCT01947478 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT01947478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01947478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of MDT-2113 Drug-Eluting Balloon (DEB) vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery
Lead sponsor
Medtronic Endovascular
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2013
Completion date
April 30, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoral artery occlusion, femoral artery stenosis, popliteal artery occlusion, popliteal artery stenosis